or
Bookmark and Share
Calcium glutarate supplement and phosphorus binder
   
Document Number
US Patent 6887897
Issued Date
May 3, 2005
Link
Inventors
Map
Abstract
Methods of controlling calcium intake and phosphate metabolism and metabolic acidosis in patients suffering from renal failure and associated hyperphosphatemia or patients predisposed to development of a hyperphosphatemic condition are provided. The method in accordance with this invention comprises administering to a patient a calcium glutarate compound. Therapeutic benefit can be realized in accordance with such method by administering the compound orally to a patient to increase available calcium and contact and bind with ingested phosphate in the patient's digestive tract, and thereby prevent its intestinal absorption.
Tags:
Description:
Amusing 0%
Clever 0%
Complex 0%
Efficient 0%
Historic 0%
Important 0%
Innovative 0%
Interesting 0%
Practical 0%
Simple 0%
Number of Claims:
26
Comments:
no comments yet
Owner
Mission Pharmacal Company (San Antonio, TX)
Published
May 3, 2005
Application Number
09/919,025
Filed
July 31, 2001
US Classification
514/492   514/557 514/574 514/578 514/891
Int'l Classification
A61K   31/194   (20060101)   A61K   31/185   (20060101)  
Examiner
Assistant Examiner
Attorney/Law Firm
USPTO Field of Search
424/451   424/464   424/43   424/682   424/490   514/492   514/557   514/574   514/578   514/891   514/54   514/60  
Related Patents
Claims
Description
About| FAQs| Terms & Disclaimer| Link to Us| Contact Us